Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif

(2014) Katja Jehle et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Evolution of androgen receptor targeted therapy for advanced prostate cancer

(2014) Yien Ning Sophia Wong et al.   Nature Reviews Clinical Oncology

The Mutational Landscape of Prostate Cancer

(2013) Christopher E. Barbieri et al.   EUROPEAN UROLOGY

Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives

(2013) Ravi Shashi Nayana Munuganti et al.   JOURNAL OF MEDICINAL CHEMISTRY

An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)

(2013) M. Korpal et al.   Cancer Discovery

A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509

(2013) J. D. Joseph et al.   Cancer Discovery

The Androgen Receptor in Health and Disease

(2012) Takahiro Matsumoto et al.   Annual Review of Physiology

Combination Therapy of Antiandrogen and XIAP Inhibitor for Treating Advanced Prostate Cancer

(2012) Michael Danquah et al.   PHARMACEUTICAL RESEARCH

The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional Activity

(2012) Colin W. Hay et al.   PLoS One

Overview of theCCP4 suite and current developments

(2011) Martyn D. Winn et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Androgen receptor coregulators: Recruitment via the coactivator binding groove

(2011) Dennis J. van de Wijngaart et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Androgen receptor signaling and mutations in prostate cancer

(2010) Shahriar Koochekpour   ASIAN JOURNAL OF ANDROLOGY

FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth

(2010) G. N. Brooke et al.   CANCER RESEARCH

TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells

(2009) Eleonora Costantino et al.   CANCER LETTERS

The Role of Androgen Receptor Mutations in Prostate Cancer Progression

(2009) G. Brooke et al.   CURRENT GENOMICS

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours

(2009) D Alwyn Dart et al.   ENDOCRINE-RELATED CANCER

Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer

(2009) Amjad P. Khan et al.   MOLECULAR & CELLULAR PROTEOMICS

Microarray coupled to quantitative RT–PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells

(2009) S Ngan et al.   ONCOGENE

Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases

(2009) Adaikkalam Vellaichamy et al.   PLoS One